Internal Medicine, Hematology & Oncology · Flint, MI
NPI
1811377807
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
302 Kensington Ave
Flint, MI, 48503
Phone (810) 762-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
99,730 services
Medicare patients, 2024
456
Average age 73
Drug cost, 2024
$2.8M
1,554 prescriptions
Company payments, 2025
$2,911
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alyssa Kipke was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 39,780 times for 62 patients. In total Alyssa Kipke billed 99,730 services in 103 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 39,780 | 62 | $0.26 | $10K |
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 19 | $20.23 | $63K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 996 | 16 | $6.39 | $6,360 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 685 | 30 | $0.09 | $61.57 |
| 85025 Blood Count | Office | 682 | 254 | $7.52 | $5,126 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 480 | 22 | $0.68 | $326 |
| Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 324 | 14 | $112.60 | $36K |
| 96372 Injection Administration | Office | 271 | 70 | $10.22 | $2,770 |
| 99214 Office E&M - Established | Office | 244 | 107 | $90.98 | $22K |
| 96367 Intravenous Infusion, Hydration | Office | 128 | 35 | $20.53 | $2,627 |
| 96365 Intravenous Infusion, Hydration | Office | 126 | 70 | $44.20 | $5,569 |
| 96413 Chemotherapy Administration | Office | 122 | 45 | $92.02 | $11K |
| 99213 Office E&M - Established | Office | 120 | 98 | $54.22 | $6,506 |
| 96375 Injection Administration | Office | 114 | 33 | $11.02 | $1,256 |
| 99222 Hospital E&M - Initial | Facility | 95 | 87 | $96.87 | $9,202 |
By year: 2022 $672K for 47,926 services; 2023 $1.0M for 61,781 services; 2024 $1.3M for 99,730 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 682 | 254 | $7.52 | $5,126 |
Medicare prescription drug claims, 2024
In 2024, the drug Alyssa Kipke prescribed most often to Medicare patients was Anastrozole, with 150 prescriptions and refills. In total Alyssa Kipke wrote 1,554 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 150 | 419 | 51 | $15K |
| Exemestane Generic | 139 | 389 | 43 | $39K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 103 | 103 | 37 | $2,034 |
| Eliquis Apixaban | 65 | 77 | 16 | $44K |
| Alendronate Sodium Generic | 64 | 112 | 11 | $735 |
| Prochlorperazine Maleate Generic | 58 | 59 | 40 | $804 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 46 | 46 | 31 | $479 |
| Ibrance Palbociclib | 41 | 41 | Under 11 | $658K |
| Ondansetron Odt Ondansetron | 41 | 44 | 39 | $1,127 |
| Alprazolam Generic | 39 | 39 | 11 | $125 |
| Acyclovir Generic | 33 | 43 | 11 | $537 |
| Letrozole Generic | 30 | 78 | Under 11 | $1,007 |
| Anagrelide Hcl Generic | 28 | 36 | Under 11 | $3,641 |
| Gabapentin Generic | 27 | 29 | Under 11 | $453 |
| Dexamethasone Generic | 26 | 35 | 14 | $387 |
Brand drugs: 306 claims; generic drugs: 1,248 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alyssa Kipke $2,911 ($2,911 in general payments such as food, travel and fees) from 42 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,356.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 28 | $1,356 |
| Janssen Biotech, Inc. JNJ | 10 | $173 |
| Legend Biotech USA Inc. LEGN | 6 | $137 |
| Genentech USA, Inc. ROG.SW | 3 | $80.52 |
| GlaxoSmithKline, LLC. GSK | 4 | $78.63 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $54.11 |
| Genzyme Corporation SNY | 2 | $51.73 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.42 |
| Pfizer Inc. PFE | 3 | $49.75 |
| Genmab U.S., Inc. GMAB | 2 | $49.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.